Growth Factors and Their Receptors

  • C.-H. Heldin
  • B. Westermark
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 94 / 2)

Abstract

The growth of cells in culture is controlled by polypeptide hormones that stimulate or inhibit proliferation. More than 20 different growth factors have been extensively characterised, and the corresponding cDNAs have been cloned (Table 1). Several additional growth factors are known from their biological activities but have not yet been structurally characterised. The in vivo functions of growth factors are assumed to be the stimulation of fetal and placental growth during development, the regulation of the growth and differentiation of continuously regenerating tissues, e.g. in haematopoiesis, and the stimulation of tissue repair processes. Specific growth inhibitory polypeptides have also recently been identified. Transforming growth factor (TGF)-β and the interferons are the most well studied, but it is anticipated that additional growth inhibitors will be found. The functions of growth inhibitors in vivo remain to be elucidated; it is possible that they have a role in the feedback inhibition of cell growth and regulation of cell differentiation.

Keywords

Epidermal Growth Factor Receptor Protein Tyrosine Kinase PDGF Receptor Autocrine Stimulation Haemopoietic Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abraham JA, Whang JL, Tumolo A, Mergia A, Friedman J, Gospodarowicz D, Fiddes JC (1986) Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J 5:2523–2528PubMedGoogle Scholar
  2. Adkins B, Leutz A, Graf T (1984) Autocrine growth induced by src-related oncogenes in transformed chicken myeloid cells. Cell 39:439–445PubMedGoogle Scholar
  3. Anzano MA, Roberts AB, Smith JM, Sporn MB, De Larco JE (1983) Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type a and type /? transforming growth factors. Proc Natl Acad Sci USA 80:6264–6268PubMedGoogle Scholar
  4. Arima N, Daitoku Y, Oghald S, Fukumori J, Tanaka H, Yamamoto Y, Fujimoto K, Onoue K (1986) Autocrine growth of interleukin 2-produeing leukemic cells in a patient with adult T cell leukemia. Blood 68:779–782PubMedGoogle Scholar
  5. Arya SL, Wong-Staal F, Gallo RC (1984) T-cell growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells. Science 223:1086–1087PubMedGoogle Scholar
  6. Balduzzi PC, Notter MDF, Morgan HR, Shibuya M (1981) Some biological properties of two new avian sarcoma viruses. J Virol 40:268–275PubMedGoogle Scholar
  7. Bargmann CI, Hung M-C, Weinberg RA (1986 a) The neu oncogene encodes an epidermal growth factor receptor related protein. Nature 319:226–230PubMedGoogle Scholar
  8. Bargmann CI, Hung M-C, Weinberg RA (1986 b) Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of pi 85. Cell 45:649–657PubMedGoogle Scholar
  9. Beckmann MP, Betsholtz C, Heldin C-H, Westermark B, Di Marco E, Di Fiore PP, Rob- bins KC, Aaronson SA (1988) Human PDGF-A and -B chains differ in their biological properties and transforming potential. Science 241:1346–1349PubMedGoogle Scholar
  10. Berridge MJ, Irvine RF (1984) Inositol trisphosphate, a novel second messenger in intracellular signal transduction. Nature 312:315–321PubMedGoogle Scholar
  11. Besmer P, Snyder HW Jr, Murphy JE, Hardy WD Jr, Parodi A (1983) The Parodi-Irgens feline sarcoma virus and simian sarcoma virus have homologous oncogenes but in different contexts of the viral genomes. J Virol 46:606–613PubMedGoogle Scholar
  12. Besmer P, Murphy JE, George PC, Qui F, Bergold PJ, Lederman L, Synder HW Jr, Brodeur D, Zuckerman EE, Hardy WD (1986) A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320:415–421PubMedGoogle Scholar
  13. Betsholtz C, Westermark B, Ek B, Heldin C-H (1984) Coexpression of a PDGF-like growth factor and PDGF receptors in a human osteosarcoma cell line. Implications for autocrine receptor activation. Cell 39:447–457Google Scholar
  14. Betsholtz C, Johnsson A, Heldin C-H, Westermark B, Lind P, Urdea MS, Eddy R, Shows TB, Philpott K, Mellor AL, Knott TJ, Scott J (1986 a) cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumor cell lines. Nature 320:695–699PubMedGoogle Scholar
  15. Betsholtz C, Johnsson A, Heldin C-H, Westermark B (1986 b) Efficient reversion of SSV- transformation and inhibition of growth factor-induced mitogenesis by suramin. Proc Natl Acad Sci USA 83:6440–6444PubMedGoogle Scholar
  16. Betsholtz C, Bergh J, Bywater-Ekegard M, Pettersson M, Johnsson A, Heldin C-H, Ohlsson R, Scott J, Bell G, Westermark B (1987) PDGF production in human lung cancer cells suggestes a role in tumor stroma formation. Int J Cancer 39:502–507PubMedGoogle Scholar
  17. Beug H, Hayman MJ, Raines MB, Kung HJ, Vennstrom B (1986) Rous-associated virus 1- induced erythroleukemic cells exhibit a weakly transformed phenotype in vitro and release c-erbB-contmning retroviruses unable to transform fibroblasts. J Virol 57:1127–1138PubMedGoogle Scholar
  18. Bigner SH, Wong AJ, Mark J, Kinzler KW, Yogelstein B, Bigner DD (1987) Relationships between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genet Cytogenet 29:165–170PubMedGoogle Scholar
  19. Bringman TS, Lindquist PB, Derynck R (1987) Different transforming growth factor-a species are derived from a glycosylated and palmitoylated transmembrane precursor. Cell 48:429–440PubMedGoogle Scholar
  20. Bronzert DA, Pantazis P, Antoniades HN, Kasid A, Davidson N, Dickson RB, Lippman ME (1987) Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci USA 84:5763–5767PubMedGoogle Scholar
  21. Brown MA, Pierce JH, Watson CJ, Falco J, Ihle JN, Paul WE (1987) B cell stimulatory factor-l/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 50:809–818PubMedGoogle Scholar
  22. Browning PJ, Bunn HF, Cline A, Shuman M, Nienhius AW (1986) “Replacement” of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential. Proc Natl Acad Sci USA 83:7800–7804PubMedGoogle Scholar
  23. Bywater M, Rorsman F, Bongcam-Rudloff E, Mark G, Hammacher A, Heldin C-H, Westermark B, Betsholtz C (1988) Expression of recombinant PDGF A- and B-chain homodimers in rat-1 cells and human fibroblasts reveals differences in protein processing and autocrine effects. Mol Cell Biol 8:2753–2762PubMedGoogle Scholar
  24. Campbell HD, Tucker WQJ, Hort Y, Martinson ME, Mayo G, Clutterbuck EJ, Sanderson CJ, Young IG (1987) Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). Proc Natl Acad Sci USA 84:6629–6633PubMedGoogle Scholar
  25. Cantrell DA, Smith KA (1984) The interleukin-2 T-cell system: a new cell growth model. Science 224:1312–1316PubMedGoogle Scholar
  26. Carpenter G (1987) Receptors for epidermal growth factor and other polypeptide mitogens. Ann Rev Biochem 56:881–914PubMedGoogle Scholar
  27. Chen SJ, Holbrook NJ, Mitchell KF, Vallone CA, Freegard JS, Crabtree GR, Lin Y (1985) A viral long terminal repeat in the interleukin 2 gene of a cell line that constitu- tively produces interleukin 2. Proc Natl Acad Sci USA 82:7284–7288PubMedGoogle Scholar
  28. Claesson-Welsh L, Eriksson A, Moren A, Severinsson L, Ek B, Ostman A, Betsholtz C, Heldin C-H (1988) cDNA cloning and expression of a human PDGF receptor specific for B chain containing molecules. Mol Cell Biol 8:3476–3486Google Scholar
  29. Clark SC, Kamen R (1987) The human hematopoietic colony-stimulating factors. Science 236:1229–1237PubMedGoogle Scholar
  30. Clarke MF, Westin E, Schmidt D, Josephs SF, Ratner L, Wong-Staal F, Gallo RC, Reitz MS (1984) Transformation of NIH 3T3 cells by a human c-sis cDNA clone. Nature 308:464–467PubMedGoogle Scholar
  31. Coffey RJ Jr, Derynck R, Wilcox JN, Bringman TS, Goustin AS, Moses HL, Pittelkow MR (1987) Production and auto-induction of transforming growth factor-a in human keratinocytes. Nature 328:817–820PubMedGoogle Scholar
  32. Cook WD, Metcalf D, Nicola NA, Burgess AW, Walker F (1985) Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell 41:677–683PubMedGoogle Scholar
  33. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, Vande Woude GF (1984) Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311:29–33PubMedGoogle Scholar
  34. Cooper CS, Tempest PR, Beckmann MP, Heldin C-H, Brookes P (1986) Amplification and overexpression of the met gene in spontaneously transformed NIH 3T3 mouse fibroblasts. EMBO J 5:2623–2628PubMedGoogle Scholar
  35. Cotton PC, Brugge JS (1983) Neural tissues express high levels of the cellular src gene product, pp60c“src. Mol Cell Biol 3:1157–1162PubMedGoogle Scholar
  36. Coughlin SR, Lee WMF, Williams PW, Giels GM, Williams LT (1985) c-myc gene expression is stimulated by agents that activate protein kinase C and does not account for the mitogenie effect of PDGF. Cell 43:243–251Google Scholar
  37. Coussens L, Yang-Feng TL, Liao Y-C, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schessinger J, Francke U, Levinson A, Ullrich A (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132–1139PubMedGoogle Scholar
  38. Coussens L, Van Beveren C, Smith D, Chen E, Mitchell RL, Isacke CM, Verma IM, Ullrich A (1986) Structural alteration of viral homologue of receptor protooncogene fms at carboxyl terminus. Nature 320:277–280PubMedGoogle Scholar
  39. Cowley G, Smith J A, Gusterson B, Hendler F, Ozanne B (1984) The amount of EGF receptor is elevated in squamous cell carcinomas. Cancer Cells 1:5–10Google Scholar
  40. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JND (1985) Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316:823–826PubMedGoogle Scholar
  41. De Larco JE, Todaro GJ (1978) Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 75:4001–4005PubMedGoogle Scholar
  42. Delli Bovi P, Curatola AM, Kern FG, Greco A, Ittmann M, Basilico C (1987) An oncogene isolated by transfection of Kaposi’s sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 50:729–737Google Scholar
  43. Derynck R, Roberts AB, Winkler ME, Chen EY, Goeddel DV (1984) Human transforming growth factor-a: precursor structure and expression in E. coli. Cell 38:287–297Google Scholar
  44. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH (1987) Synthesis of messenger RNA for transforming growth factors a and f$ and the epidermal growth factor receptor by human tumors. Cancer Res 47:707–712PubMedGoogle Scholar
  45. Devare SG, Reddy EP, Law JD, Robbins KC, Aaronson SA (1983) Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis. Proc Natl Acad Sci USA 80:731–735PubMedGoogle Scholar
  46. Dickson C, Peters G (1987) Potential oncogene product related to growth factors. Nature 326:833PubMedGoogle Scholar
  47. Doolittle RF, Hunkapiller MW, Hood LE, Devare SG, Robbins KC, Aaronson SA, Antoniades HN (1983) Simian sarcoma virus oncogene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221:275–277PubMedGoogle Scholar
  48. Downward J, Parker P, Waterfield MD (1984 a) Autophosphorylation sites on the epidermal growth factor receptor. Nature 311:483–485PubMedGoogle Scholar
  49. Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD (1984 b) Close similarity of epidermal growth factor receptor and v- erb-B oncogene protein sequences. Nature 307:521–527PubMedGoogle Scholar
  50. Duprez V, Lenoir G, Dautry-Varsat A (1985) Autocrine growth stimulation of a human T-cell lymphoma line by interleukin 2. Proc Natl Acad Sci USA 82:6932–6936PubMedGoogle Scholar
  51. Durum SV, Schmidt TA, Opperheim TT (1985) Interleukin 1: an immunological perspective. Ann Rev Immunol 3:263–287Google Scholar
  52. Fernandez-Botran R, Sanders VM, Olivier KG, Chen Y-W, Krammer PH, Uhr JW, Vitetta ES (1986) Interleukin 4 mediates autocrine growth of helper T cells after antigenic stimulation. Proc Natl Acad Sci USA 83:9689–9693PubMedGoogle Scholar
  53. Ferrara N, Schweigerer L, Neufeld G, Mitchell R, Gospodarowicz D (1987) Pituitary follicular cells produce basic fibroblast growth factor. Proc Natl Acad Sci USA 84:5773–5777PubMedGoogle Scholar
  54. Ferrari S, Basegra R (1987) Oncogenes and cell cycle genes. Bioessays 7:9–13PubMedGoogle Scholar
  55. Finzi E, Fleming T, Segatto O, Pennington CY, Bringman TS, Derynck R, Aaronson SA (1987) The human transforming growth factor type a coding sequences is not a direct- acting oncogene when overexpressed in NIH 3T3 cells. Proc Natl Acad Sci USA 84:3733–3737PubMedGoogle Scholar
  56. Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235:442–447PubMedGoogle Scholar
  57. Fukushige S-I, Matsubara K-I, Yoshida M, Sasaki M, Suzuki T, Semba K, Toyoshima K, Yamamoto T (1986) Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol Cell Biol 6:955–958PubMedGoogle Scholar
  58. Gazit A, Igarashi H, Chiù I-M, Srinivasan A, Yaniv A, Tronick SR, Robbins KC, Aaronson SA (1984) Expression of the normal human sis/PDGF-2 coding sequence induces cellular transformation. Cell 39:80–97Google Scholar
  59. Gentry LE, Twardzik DR, Lim GJ, Ranchalis JE, Lee DC (1987) Expression and characterization of transforming growth factor a precursor protein in transfected mammalian cells. Mol Cell Biol 7:1585–1591PubMedGoogle Scholar
  60. Gilmore T, DeClue JE, Martin GS (1985) Protein phosphorylation at tyrosine is induced by the v-erbB gene product in vivo and in vitro. Cell 40:609–618PubMedGoogle Scholar
  61. Gisselbrecht S, Fichelson S, Sola B, Bordereaux D, Hampe A, André C, Galibert F, Tambourin P (1987) Frequent c -fins activation by pro viral insertion in mouse myeloblastie leukemias. Nature 329:259–261PubMedGoogle Scholar
  62. Golden A, Nemeth SP, Brugge JS (1986) Blood platelets express high levels of the pp60c“src-specific tyrosine kinase activity. Proc Natl Acad Sci USA 83:852–856PubMedGoogle Scholar
  63. Gootenberg JE, Ruscetti FW, Mier JW, Gazdar A, Gallo RC (1981) T-cell lymphoma and leukemia cell lines produce and respond to T-cell growth factor. J Exp Med 154:1403–1418PubMedGoogle Scholar
  64. Gospodarowicz D, Neufeld D, Schweigerer L (1986) Fibroblast growth factor. Mol Cell Endocrinol 46:187–204PubMedGoogle Scholar
  65. Gough NM (1986) The granulocyte-macrophage colony-stimulating factors. In: Kahn P, Graf T (eds) Oncogenes and growth control. Springer, Berlin Heidelberg New York, pp 35–42Google Scholar
  66. Goustin AS, Betsholtz C, Pfeifer-Ohlsson S, Persson H, Rydnert J, Bywater M, Holmgren G, Heldin C-H, Westermark B, Ohlsson R (1985) Co-expression of the sis and myc proto-oncogenes in human placenta suggest autocrine control of trophoblast growth. Cell 41:301–312PubMedGoogle Scholar
  67. Graf T, v. Weizsäcker F, Grieser S, Coll J, Stehelin D, Patschinsky T, Bister K, Bechade C, Calothy G, Leutz A (1986) v-mil induces autocrine growth and enhanced tumorigenicity in v-myc transformed avian macrophages. Cell 45:357–364PubMedGoogle Scholar
  68. Gray A, Dull TJ, Ullrich A (1983) Nucleotide sequence of epidermal growth factor cDNA predicts a 128 000-molecular weight protein precursor. Nature 303:722–725PubMedGoogle Scholar
  69. Gullick WJ, Marsden JJ, Whittle N, Ward B, Bobrow L, Waterfield MD (1986) Expression of epidermal growth factor receptors on human cervical, ovarian and vulval carcinomas. Cancer Res 46:285–292PubMedGoogle Scholar
  70. Gusterson B, Cowley G, Mcllhinney J, Ozanne B, Fisher C, Reeves B (1985) Evidence for increased epidermal growth factor receptors in human sarcomas. Int J Cancer 36:689–693PubMedGoogle Scholar
  71. Haegeman G, Content J, Volckaert G, Derynck R, Tavernier J, Fiers W (1986) Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem 159:625–632PubMedGoogle Scholar
  72. Hammacher A, Hellman U, Johnsson A, Östman A, Gunnarsson K, Westermark B, Wasteson Ä, Heldin C-H (1988 a) A major part of PDGF purified from human platelets is a heterodimer of one A and one B chain. J Biol Chem 263:16493–16498Google Scholar
  73. Hammacher A, Nistér M, Westermark B, Heldin C-H (1988 b) A human glioma cell line secretes three structurally and functionally different dimeric forms of PDGF. Eur J Biochem 176:179–186Google Scholar
  74. Hannink M, Donoghue DJ (1984) Requirement for a signal sequence in biological expression of the v-sis oncogene. Science 230:1197–1199Google Scholar
  75. Hart CE, Forstrom JW, Kelly JD, Seifert RA, Smith RA, Ross R, Murray MJ, Bowen- Pope DF (1988) Two classes of PDGF receptors recognize different isoforms of PDGF. Science 240:1529–1531PubMedGoogle Scholar
  76. Heldin C-H, Rönnstrand L (1989) The platelet-derived growth factor receptor. In: Moudgil VK (ed) Receptor phosphorylation. CRC Press, Boca Raton, FL, pp 149–162Google Scholar
  77. Heldin C-H, Wasteson A, Westermark B (1985) Platelet-derived growth factor. Mol Cell Endocrinol 39:169–187PubMedGoogle Scholar
  78. Heldin C-H, Johnsson A, Wennergren S, Wernstedt C, Betsholtz C, Westermark B (1986) A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A chains. Nature 319:511–514PubMedGoogle Scholar
  79. Heldin C-H, Betsholtz C, Claesson-Welsh L, Westermark B (1987) Subversion of growth regulatory pathways in malignant transformation. Biochim Biophys Acta 907:219–244PubMedGoogle Scholar
  80. Heldin C-H, Bäckström G, Östman A, Hammaeher A, Rönnstrand L, Rubin K, Nister M, Westermark B (1988) Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. EMBO J 7:1387–1394PubMedGoogle Scholar
  81. Hendler FJ, Ozanne BW (1984) Human squamous cell lung cancers express increased epidermal growth factor receptors. J Clin Invest 74:647–651PubMedGoogle Scholar
  82. Hirai H, Maru Y, Hagiwara K, Nishida J, Takaku F (1987) A novel putative tyrosine kinase receptor encoded by the eph gene. Science 238:1717–1720PubMedGoogle Scholar
  83. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73–76PubMedGoogle Scholar
  84. Huang JS, Huang SS, Deuel TF (1984) Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors. Cell 39:79–87PubMedGoogle Scholar
  85. Hudziak RM, Schlessinger J, Ullrich A (1987) Increased expression of the putative growth factor receptor pl85HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc Natl Acad Sei USA 84:7159–7163Google Scholar
  86. Hunter T (1987) A thousand and one protein kinases. Cell 50:823–829PubMedGoogle Scholar
  87. Hunter T, Cooper JA (1985) Protein tyrosine kinases. Ann Rev Biochem 54:897–930PubMedGoogle Scholar
  88. Jacobs K, Shoemaker C, Rudersdorf R, Neill SD, Kaufman RJ, Mufson A, Seehra J, Jones SS, Hewick R, Fritsch EF, Kawakita M, Shimizu T, Miyake T (1985) Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 313:806–809PubMedGoogle Scholar
  89. Jaye M, Howk R, Burgess W, Ricca GA, Chiu I-M, Ravera MW, O'Brian SJ, Modi WS, Maeiag T, Drohan WN (1986) Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. Science 233:541–545PubMedGoogle Scholar
  90. Johnsson A, Betsholtz C, Heldin C-H, Westermark B (1985) Antibodies against platelet- derived growth factor inhibit acute transformation by simian sarcoma virus. Nature 317:438–440PubMedGoogle Scholar
  91. Johnsson A, Betsholtz C, Heldin C-H, Westermark B (1986) The phenotypic characteristics of simian sarcoma virus-transformed human fibroblasts suggest that the w-sis gene product acts solely as a PDGF receptor agonist in cell transformation. EMBO J 5:1535–1541PubMedGoogle Scholar
  92. Josephs SF, Ratner L, Clarke MF, Westin EH, Reitz MS, Wong-Staal F (1984) Transforming potential of human c-sis nucleotide sequences encoding platelet-derived growth factor. Science 225:636–639PubMedGoogle Scholar
  93. Kahn P, Frykberg L, Bradly C, Stanley I, Beug H, Vennström B, Graf T (1986) v-erbA cooperates with sarcoma oncogenes in leukemic cell transformation. Cell 45:349–356PubMedGoogle Scholar
  94. Kaplan PL, Ozanne B (1982) Polyoma virus-transformed cells produce transforming growth factor(s) and grow in serum-free medium. Virology 123:372–380PubMedGoogle Scholar
  95. Kaplan PL, Andersson M, Ozanne B (1982) Transforming growth factor(s) production enables cells to grow in the absence of serum: an autocrine system. Proc Natl Acad Sei USA 79:485–489Google Scholar
  96. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332:83–85PubMedGoogle Scholar
  97. Kinashi T, Harada N, Severinson E, Tanabe T, Sideras P, Konishi M, Azuma C, Tominaga A, Bergstedt-Lindquist S, Takahashi M, Matsuda F, Yaoita Y, Takatsu K, Honjo T (1986) Cloning of complementary DNA encoding T-cell replacing factor and identity with B-eell growth factor II. Nature 324:70–73PubMedGoogle Scholar
  98. King CR, Giese NA, Robbins KC, Aaronson SA (1985 a) In vitro mutagenesis of the v-sis transforming gene defines functional domains of its growth factor-related product. Proc Natl Acad Sei USA 82:5295–5299Google Scholar
  99. King CR, Kraus MH, Aaronson SA (1985 b) Amplification of a novel v-erbB-rdated gene in a human mammary carcinoma. Science 229:974–976Google Scholar
  100. Klagsbrun M, Sasse J, Sullivan R, Smith JA (1986) Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor. Proc Natl Acad Sei USA 83:2448–2452Google Scholar
  101. Kohase M, Henriksen-DeStefano D, May LT, Vilcek J, Sehgal PB (1986) Induction of ß2- interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 45:659–666PubMedGoogle Scholar
  102. Kozma SC, Redmond SMS, Xiao-Chang F, Saurer SM, Groner B, Hynps N (1988) Activation of the tyrosine kinase domain of the trk oncogene by recombination with two different cellular sequences. EMBO J 7:147–154PubMedGoogle Scholar
  103. Kraus MH, Popescu NC, Amsbaugh SC, King CR (1987) Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6:605–610PubMedGoogle Scholar
  104. Kris RM, Lax I, Gullick W, Waterfield MD, Ullrich A, Fridkin M, Schlessinger J (1985) Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB proteins. Cell 40:619–625PubMedGoogle Scholar
  105. Laker C, Stocking C, Bergholz U, Hess N, De Lamarter JF, Ostertag W (1987) Autocrine growth stimulation after viral transfer of the granulocyte-macrophage colony stimulating factor gene and genuine factor independent growth are two distinct but interdependent steps in the oncogenic pathway. Proc Natl Acad Sei USA 84:8458–8462Google Scholar
  106. Lang RA, Metealf D, Gough NM, Dunn AR, Gonda TJ (1985) Expression of a hemopoietic growth factor cDNA in a factor-dependent cell line results in autonomous growth and tumorigenicity. Cell 43:531–542PubMedGoogle Scholar
  107. Lax I, Kris R, Sasson I, Ullrich A, Hayman MJ, Beug H, Schlessinger J (1985) Activation of c-erbB in avian leukosis virus-induced erythroblastosis leads to the expression of a truncated EGF receptor kinase. EMBO J 4:3179–3182PubMedGoogle Scholar
  108. Leal F, Williams LT, Robbins KC, Aaronson SA (1985) Evidence that the v-sis gene product transforms by interaction with the receptor for platelet-derived growth factor. Science 230:327–330PubMedGoogle Scholar
  109. Lee DC, Rochford R, Todaro GJ, Villarreal LP (1985) Developmental expression of rat transforming growth factor-a mRNA. Mol Cell Biol 5:3644–3646PubMedGoogle Scholar
  110. Lee F, Yokota T, Otsuka T, Meyerson P, Villaret D, Coffman R, Mosmann T, Rennick D, Roehm N, Smith C, Zlotnik A, Arai K (1986) Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor-1 activities and T-cell- and mast-cell-stimulating activities. Proc Natl Acad Sei USA 83: 2061–2065Google Scholar
  111. Leonard WJ, Depper JM, Robb RJ, Waldmann TA, Greene WC (1983) Characterization of the human receptor for T-cell growth factor. Proc Natl Acad Sei USA 80: 6957–6961Google Scholar
  112. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary brain tumours of glial origin. Nature 313:144–147PubMedGoogle Scholar
  113. Libermann TA, Friesel R, Jaye M, Lyall RM, Westermark B, Drohan W, Schmidt A, Maciag T, Schlessinger J (1987) An angiogenic growth factor is expressed in human glioma cells. EMBO J 6:1627–1632PubMedGoogle Scholar
  114. March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K, Conlon PJ, Hopp TP, Cosman D (1985) Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315:641–647PubMedGoogle Scholar
  115. Marquardt H, Hunkapiller MW, Hood LE, Twardzik DR, De Larco JE, Stephensson JR, Torado GJ (1983) Transforming growth factors produced by retrovirus transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci USA 80:4684–4688PubMedGoogle Scholar
  116. Martin-Zanca D, Hughes SH, Barbacid M (1986) A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319:743–748PubMedGoogle Scholar
  117. May LT, Helgott DC, Sehgal PB (1986) Anti-/?-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the p2 interferon involved. Proc Natl Acad Sci USA 83:8957–8961PubMedGoogle Scholar
  118. McKay I, Malone P, Marshall CJ, Hall A (1986) Malignant transformation of murine fibroblasts by a human c-Ha-ra.s-1 oncogene does not require a functional epidermal growth factor receptor. Mol Cell Biol 6:3382–3387PubMedGoogle Scholar
  119. Metcalf D (1985) The granulocyte-macrophage colony-stimulating factors. Science 229:16–22PubMedGoogle Scholar
  120. Miles BD, Robinson HL (1986) High-frequency transduction of c-erbB in avian leukosis virus-induced erythroblastosis. J Virol 54:295–303Google Scholar
  121. Mingari MC, Gerosa F, Carra G, Accolla RS, Moretta A, Zubler RH, Waldmann TA, Moretta L (1984) Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature 312:641–643PubMedGoogle Scholar
  122. Mochizuki DY, Eisenman JR, Conlon PJ, Larsen AD, Tushinski RJ (1987) Interleukin-1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. Proc Natl Acad Sci USA 84:5267–5271PubMedGoogle Scholar
  123. Moore R, Casey G, Brookes S, Dixon M, Peters G, Dickson C (1986) Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus. EMBO J 5:919–924PubMedGoogle Scholar
  124. Morgan DA, Ruscetti FW, Gallo RC (1976) Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 293:1007–1008Google Scholar
  125. Morgan DO, Edman JC, Standring DN, Fied FA, Smith MC, Roth RA, Rutter WJ (1987) Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 329:301–307PubMedGoogle Scholar
  126. Moscatelli D, Presta M, Joseph-Silverstein J, Rifkin DB (1986) Both normal and tumor cells produce basic fibroblast growth factor. J Cell Physiol 129:273–276PubMedGoogle Scholar
  127. Neckameyer WS, Shibuya M, Hsu M-T, Wang L-H (1986) Proto-oncogene c-ros codes for a molecule with structural features common to those of growth factor receptors and displays tissue-specific and developmental regulated expression. Mol Cell Biol 6:1478–1486PubMedGoogle Scholar
  128. Nilsen TW, Maroney PA, Goodwin RG, Rottman FM, Crittenden LB, Raines MA, Kung H-J (1985) c-erbB activation in ALV-induced erythroblastosis: novel RNA processing and promoter insertion result in expression of an amino-truncated EGF receptor. Cell 41:719–726PubMedGoogle Scholar
  129. Nilsson J, Euler AM v, Dalsgaard C-J (1985 a) Stimulation of connective tissue cell growth by substance P and substance K. Nature 315:61–63PubMedGoogle Scholar
  130. Nilsson J, Sjolund M, Palmberg L, Thyberg J, Heldin C-H (1985 b) Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. Proc Natl Acad Sci USA 82:4418–4422PubMedGoogle Scholar
  131. Nishizuka Y (1984) The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308:693–698PubMedGoogle Scholar
  132. Nister M, Heldin C-H, Wasteson A, Westermark B (1984) A glioma-derived analog to platelet-derived growth factor: demonstration of receptor competing activity and immunological crossreactivity. Proc Natl Acad Sci USA 81:926–930PubMedGoogle Scholar
  133. Nister M, Hammacher A, Mellstrom K, Siegbahn A, Ronnstrand L, Westermark B, Heldin C-H (1988 a) A glioma-derived PDGF A chain homodimer has different functional activities than a PDGF AB heterodimer purified from human platelets. Cell 52:791–799Google Scholar
  134. Nister M, Libermann T, Betsholtz C, Pettersson M, Claesson-Welsh L, Heldin C-H, Schlessinger J, Westermark B (1988 b) Expression of messenger RNA for platelet- derived growth factor and transforming growth factor-a and their receptors in human malignant glioma cell lines. Cancer Res 48:3910–3918Google Scholar
  135. Noma Y, Sideras P, Naito T, Bergstedt-Lindquist S, Azuma C, Severinson E, Tanabe T, Kinashi T, Matsuda F, Yaoita Y, Honjo T (1986) Cloning of cDN A encoding the murine IgGl induction factor by a novel strategy using SP6 promoter. Nature 319:640–646PubMedGoogle Scholar
  136. Nüsse R (1986) The activation of cellular oncogenes by retroviral insertion. Trends Genet 244–247Google Scholar
  137. Ohara J, Paul WE (1987) Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage. Nature 325:537–540PubMedGoogle Scholar
  138. Ozanne B, Fulton RJ, Kaplan PL (1980) Kirsten murine sarcoma virus transformed cell lines and a spontaneously transformed rat cell line produce transforming factors. J Cell Phys 105:163–180Google Scholar
  139. Pantazis P, Pelicci PG, Dalla-Favera R, Antoniades HN (1985) Synthesis and secretion of protein resembling platelet-derived growth factor by human glioblastoma and fibrosarcoma cells in culture. Proc Natl Acad Sei USA 82:2404–2408Google Scholar
  140. Park M, Dean M, Cooper CS, Schmidt M, O’Brien SJ, Blair DG, Vande Woude GF (1986) Mechanism of met oncogene activation. Cell 45:895–904PubMedGoogle Scholar
  141. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude G (1987) Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth factor receptors. Proc Natl Acad Sci USA 84:6379–6383PubMedGoogle Scholar
  142. Paulsson Y, Hammacher A, Heldin C-H, Westermark B (1987) Possible positive autocrine feed back in the prereplicative phase of human fibroblasts. Nature 318:715–717Google Scholar
  143. Perez R, Betsholtz C, Westermark B, Heldin C-H (1987) Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res 47:3425–3429Google Scholar
  144. Pierce JH, Di Fiore PP, Aaronson SA, Potter M, Pumphrey J, Scott A, Ihle JN (1985) Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell 41:685–693PubMedGoogle Scholar
  145. Pollard JW, Bartocci A, Arceci R, Orlofsky A, Ladner MB, Stanley ER (1987) Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature 330:484–487PubMedGoogle Scholar
  146. Raines MA, Lewis WG, Crittenden LB, Kung H-J (1985) c-erbB activation in avian leukosis virus-induced erythroblastosis: clustered integration sites and the arrangement of ALV provirus in the c-erbB alleles. Proc Natl Acad Sei USA 82:2287–2291Google Scholar
  147. Riedel H, Schlessinger J, Ullrich A (1987) A chimeric, ligand-binding v-erbB/EGF receptor retains transforming potential. Science 236:197–200PubMedGoogle Scholar
  148. Rijsewik F, Schuermann M, Wagenaar E, Parren P, Weigel D, Nüsse R (1987) The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 50:649–657Google Scholar
  149. Robbins KC, Antoniades HN, Devare SG, Hunkapiller MW, Aaronson SA (1983) Structural and immunological similarities between simian sarcoma virus gene product(s) and human platelet-derived growth factor. Nature 305:605–608PubMedGoogle Scholar
  150. Rogelj S, Weinberg RA, Fanning P, Klagsbrun M (1988) Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature 331:173–175PubMedGoogle Scholar
  151. Rosenthal A, Lindquist PB, Bringman TS, Goeddel DV, Derynck R (1986) Expression in rat fibroblasts of a human transforming growth factor-a cDNA results in transformation. Cell 46:301–309PubMedGoogle Scholar
  152. Ross R, Raines EW, Bowen-Pope DF (1986) The biology of platelet-derived growth factor. Cell 46:155–169PubMedGoogle Scholar
  153. Roussel MF, Dull TJ, Rettenmier CW, Ralph P, Ullrich A, Sherr CJ (1987) Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature 325:549–552PubMedGoogle Scholar
  154. Rozengurt E, Sinnett-Smith J, Taylor-Papadimitriou J (1985) Production of PDGF-like growth factor by breast cancer cell lines. Int J Cancer 36:247–252PubMedGoogle Scholar
  155. Sacca R, Stanley ER, Sherr CJ, Rettenmier CW (1986) Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene. Proc Natl Acad Sei USA 83:3331–3335Google Scholar
  156. Sakamoto H, Mori M, Taira M, Yoshida T, Matsukawa S, Shimizu K, Sekiguchi M, Terada M, Sugimura T (1986) Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc Natl Acad Sci USA 83:3997–4001PubMedGoogle Scholar
  157. Sato M, Yoshida H, Hayashi Y, Miyakami K, Bando T, Yanagawa T, Yuna Y, Azuma M, Ueno A (1985) Expression of epidermal growth factor and transforming growth factor-/? in a human salivary gland adenocarcinoma cell line. Cancer Res 45:6160–6167PubMedGoogle Scholar
  158. Schrader JW, Crapper RM (1983) Autogenous production of a hemopoietic growth factor, persisting cell-stimulating factor as a mechanism for transformation of bone marrow-derived cells. Proc Natl Acad Sci USA 80:6892–6896PubMedGoogle Scholar
  159. Schweigerer L, Neufeld G, Mergia A, Abraham J A, Fiddes FC, Gospodarowicz D (1987) Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. Proc Natl Acad Sci USA 84:842–846PubMedGoogle Scholar
  160. Scott J, Urdea M, Quiroga M, Sanchez-Pescador R, Fong N, Selby M, Rutter WJ, Bell GI (1983) Structure of a mouse submaxillar messenger RNA encoding epidermal growth factor and seven related proteins. Science 221:236–240PubMedGoogle Scholar
  161. Seifert RA, Schwartz SM, Bowen-Pope DF (1984) Developmentally regulated production of platelet-derived growth factor-like molecules. Nature 311:669–671PubMedGoogle Scholar
  162. Sejersen T, Betsholtz C, Sjolund M, Heldin C-H, Westermark B, Thyberg J (1986) Rat skeletal myoblasts and arterial smooth muscle cells express the gene for the A chain but not the B chain (c-sis) of platelet-derived growth factor (PDGF) and produce a PDGF- like protein. Proc Natl Acad Sci USA 83:6844–6848PubMedGoogle Scholar
  163. Semba K, Kamata N, Toyoshima K, Yamamoto T (1985) A v-erbB related protoon- cogene, c-erbB-2, is distinct from the c-erbB-1 /epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci USA 82:6497–6501PubMedGoogle Scholar
  164. Sharon M, Klausner RD, Cullen BR, Chizzonite R, Leonard WJ (1986) Novel interleukin- 2 receptor subunit detected by cross-linking under high-affinity conditions. Science 234:859–863PubMedGoogle Scholar
  165. Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER (1985) The c-fins proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665–676PubMedGoogle Scholar
  166. Sherwin SA, Twardzik DR, Bohn WH, Cockley KD, Todaro GJ (1983) High molecular- weight transforming growth factor activity in the urine of patients with disseminating cancer. Cancer Res 43:403–407PubMedGoogle Scholar
  167. Shibuya M, Hanafusa H, Balduzzi PC (1982) Cellular sequences related to three new one genes of avian sarcoma (fps, yes, and ros) and their expression in normal and transformed cells. J Virol 42:143–152PubMedGoogle Scholar
  168. Sibley DR, Benovic JL, Caron MG, Lefkowitz RJ (1987) Regulation of transmembrane signaling by receptor phosphorylation. Cell 48:913–922PubMedGoogle Scholar
  169. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182PubMedGoogle Scholar
  170. Smith JJ, Derynck R, Korc M (1987) Production of transforming growth factor a in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. Proc Natl Acad Sci USA 84:7567–7570PubMedGoogle Scholar
  171. Soderdahl G, Betsholtz C, Johansson A, Nilsson K, Berg J (1988) Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small cell human lung carcinoma cell lines. Int J Cancer 41:636–641PubMedGoogle Scholar
  172. Sporn MB, Roberts AB (1985) Autocrine growth factors and cancer. Nature 313:745–747PubMedGoogle Scholar
  173. Sporn MB, Todaro GJ (1980) Autocrine secretion and malignant transformation of cells. N Engl J Med 303:878–880PubMedGoogle Scholar
  174. Stanley ER, Guilbert LJ, Tushinski RJ, Bartelmez SH (1983) CSF-1 a mononuclear phagocyte lineage-specific hemopoietic growth factor. J Cell Biochem 21:151–159PubMedGoogle Scholar
  175. Stern DF, Hare DL, Cecchini MA, Weinberg RA (1987) Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. Science 235:321–324PubMedGoogle Scholar
  176. Stroobant P, Waterfield MD (1984) Purification and properties of porcine platelet-derived growth factor. EMBO J 3:2963–2967PubMedGoogle Scholar
  177. Stroobant P, Rice AP, Gullick WJ, Chen DJ, Kerr IM, Waterfield MD (1985) Purification and characterization of vaccinia virus growth factor. Cell 42:383–393PubMedGoogle Scholar
  178. Taira M, Yoshida T, Miyagawa K, Sakamoto H, Terada M, Sugimura T (1987) cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc Natl Acad Sci USA 84:2980–2984PubMedGoogle Scholar
  179. Takahashi M, Cooper GM (1987) ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 7:1378–1385PubMedGoogle Scholar
  180. Taniguchi T, Matsui H, Fujita Y, Hatakeymana M, Kashima N, Fuse A, Hamuro J, Hishi-Takaoka C, Yamada G (1986) Molecular analysis of the interleukin-2 system. Immunol Rev 92:121–133PubMedGoogle Scholar
  181. Teixido J, Gilmore R, Lee DC, Massague J (1987) Integral membrane glycoprotein properties of the prohormone pro-transforming growth factor-a. Nature 326:883–885PubMedGoogle Scholar
  182. Temin HM (1966) Control by factors in serum of multiplication of uninfected cells and cells infected and converted by avian sarcoma viruses. In: Defendi V, Stoker M (eds) Growth regulating substances for animal cells in cultures. Wistar symposium monograph no. 7, Wistar Institute Press, Philadelphia, PA, pp 103–116Google Scholar
  183. Todaro GJ, DeLarco JE, Marquardt H, Bryant ML, Sherwin SA, Sliski AH (1979) Polypeptide growth factors produced by tumor cells and virus-transformed cells: a possible growth advantage for the producer cells (1979). In: Sato GH, Ross R (eds) Hormones and cell culture, book A, Cold Spring Harbor conferences on cell proliferation, 6. Cold Spring Harbor, New York, pp 113–127Google Scholar
  184. Todaro GJ, Fryling C, DeLarco JE (1980) Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 77:5258–5262PubMedGoogle Scholar
  185. Twardzik DR (1985) Differential expression of transforming growth factor-a during prenatal development of the mouse. Cancer Res 45:5413–5416PubMedGoogle Scholar
  186. Twardzik DR, Todaro GJ, Marquardt H, Reynolds FH Jr, Stephenson JR (1982) Transformation induced by Abelson murine leukemia virus involves production of a polypeptide growth factor. Science 216:894–896PubMedGoogle Scholar
  187. Twardzik DR, Todaro GJ, Reynolds FH Jr, Stephenson JR (1983) Similar transforming growth factors (TGFs) produced by cells transformed by different isolates of feline sarcoma virus. Virology 124:201–207Google Scholar
  188. Twardzik DR, Brown JP, Ranchalis JE, Todaro GJ, Moss B (1985) Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors. Proc Natl Acad Sci USA 82:5300–5304PubMedGoogle Scholar
  189. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309:418–425PubMedGoogle Scholar
  190. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzelli LM, Dull TJ, Gray A, Coussens L, Liao Y-C, Tsubokawa M, Mason A, Seeburg PH, Grunfeld C, Rosen OM, Ramachandran J (1985) Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 311:756–761Google Scholar
  191. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J, Fujita-Yamaguchi Y (1986) Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503–2512PubMedGoogle Scholar
  192. Van de Vijver M, van de Bersselaar R, Devilee P, Cornelisse C, Peterse J, Nusse R (1987) Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol Cell Biol 7:2019–2023PubMedGoogle Scholar
  193. Van Ooyen A, Nusse R (1984) Structure and nucleotide sequence of the putative mammary oncogene int-1 pro viral insertions leave the protein encoding domain intact. Cell 39:233–240PubMedGoogle Scholar
  194. Van Snick J, Cayphas S, Vink A, Uyttenhove C, Coulie PG, Rubira MR, Simpson RJ (1986) Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 83:9679–9683PubMedGoogle Scholar
  195. Verbeek JS, de Ruyter O, Bloemers HPJ, Van de Ven WJM (1985) Molecular cloning and characterization of feline cellular genetic sequences homologous to the oncogene of the McDonough strain of feline sarcoma virus. Virology 141:322–327PubMedGoogle Scholar
  196. Vlodavsky I, Folkman J, Sullivan R, Friedman R, Ishai-Michaeli R, Sasse J, Klagsbrun M (1987) Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sei USA 84:2292–2296Google Scholar
  197. von Weizsäcker F, Beug H, Graf T (1986) Temperature-sensitive mutants of MH2 avian leukemia virus that map in the v-mil and v-myc genes of the virus. EMBO J 5:1521–1528Google Scholar
  198. Watanabe S, Lazar E, Sporn MB (1987) Transformation of normal rat kidney (NRK) cells by an infectious retrovirus carrying a synthetic rat type a transforming growth factor gene. Proc Natl Acad Sei USA 84:1258–1262Google Scholar
  199. Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnsson A, Wasteson A, Westermark B, Heldin C-H, Huang JS, Deuel TF (1983) Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 304:35–39PubMedGoogle Scholar
  200. Westermark B, Heldin C-H (1988) Activation of protooncogenes coding for growth factors or growth factor receptors. In: Klein G (ed) Cellular oncogene activation. Dekker, New York, pp 149–180Google Scholar
  201. Westermark B, Johnsson A, Paulsson Y, Betsholtz C, Heldin C-H, Herlyn M, Rodeck U, Koprowski H (1986) Human melanoma cell lines of primary and metastatic origin express the genes encoding the constituent chains of PDGF and produce a PDGF-like growth factor. Proc Natl Acad Sci USA 83:7197–7200PubMedGoogle Scholar
  202. Westermark B, Betsholtz C, Johnsson A, Heldin C-H (1987) Acute transformation by simian sarcoma virus is mediated by an externalized PDGF-like growth factor. In: Kjelgaard NO, Forchhammer J (eds) Viral carcinogens. Munksgaard, Copenhagen, pp 445–457Google Scholar
  203. Wheeler EF, Roussel MF, Hampe A, Walker MH, Fried VA, Look AT, Rettenmier CW, Sherr CJ (1986 a) The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of FeLV gag sequences. J Virol 59:224–233Google Scholar
  204. Wheeler EF, Rettenmier CW, Look AT, Sherr CJ (1986 b) The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line. Nature 324:377–380Google Scholar
  205. Winkles JA, Friesel R, Burgess WH, Howk R, Mehlman T, Weinstein R, Maciag T (1987) Human vascular smooth muscle cells both express and respond to heparin binding growth factor I (endothelial cell growth factor). Proc Natl Acad Sei USA 84:7124–7128Google Scholar
  206. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sei USA 84:6899–6903Google Scholar
  207. Yamamoto T, Nishida T, Miyajima N, Kawai S, Ooi T, Toyoshima K (1983) The erbB gene of avian erythroblastisis virus is a member of the sre gene family. Cell 35:71–78PubMedGoogle Scholar
  208. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K (1986 a) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319:230–234Google Scholar
  209. Yamamoto T, Kamata N, Kawano H, Shimizu S, Kuroki T, Toyoshima K, Rikimaru K, Nomura N, Ishizaki R, Pastan I, Gamou S, Shimizu N (1986 b) High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res 46:414–416PubMedGoogle Scholar
  210. Yarden Y, Escobedo JA, Kuang W-J, Yang-Feng TL, Daniel TO, Tremble PM, Chen EY, Ando ME, Harkins RN, Francke U, Fried VA, Ullrich A, Williams LT (1986) Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323:226–232PubMedGoogle Scholar
  211. Yarden Y, Kuang W-J, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schles-singer J, Francke U, Ullrich A (1987) Human protooncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341–3350PubMedGoogle Scholar
  212. Ymer S, Tucker WQJ, Sanderson CJ, Hapel AJ, Campbell HD, Young IG (1985) Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene. Nature 317:255–258PubMedGoogle Scholar
  213. Young D, Griffin JD (1986) Autocrine secretion of GM-CSF in acute myeloblasts leukemia. Blood 68:1178–1181PubMedGoogle Scholar
  214. Zacchary I, Rozengurt E (1985) High affinity receptors for peptides of the bombesin family in Swiss 3T3 cells. Proc Natl Acad Sci USA 82:7616–7620Google Scholar
  215. Zhou D, Battifora H, Yokota J, Yamamoto T, Cline MJ (1987) Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. Cancer Res 47:6123–6125PubMedGoogle Scholar
  216. Zilberstein A, Ruggieri R, Korn JH, Revel M (1986) Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growthstimulatory cytokinase. EMBO J 5:2529–2537PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • C.-H. Heldin
  • B. Westermark

There are no affiliations available

Personalised recommendations